ABSI
Price
$2.77
Change
+$0.08 (+2.97%)
Updated
Jul 3 closing price
Capitalization
353.34M
45 days until earnings call
RXRX
Price
$5.27
Change
+$0.06 (+1.15%)
Updated
Jul 3 closing price
Capitalization
2.14B
38 days until earnings call
Interact to see
Advertisement

ABSI vs RXRX

Header iconABSI vs RXRX Comparison
Open Charts ABSI vs RXRXBanner chart's image
Absci
Price$2.77
Change+$0.08 (+2.97%)
Volume$2.71M
Capitalization353.34M
Recursion Pharmaceuticals
Price$5.27
Change+$0.06 (+1.15%)
Volume$16.58M
Capitalization2.14B
ABSI vs RXRX Comparison Chart in %
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. RXRX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and RXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (ABSI: $2.77 vs. RXRX: $5.27)
Brand notoriety: ABSI and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 89% vs. RXRX: 65%
Market capitalization -- ABSI: $353.34M vs. RXRX: $2.14B
ABSI [@Biotechnology] is valued at $353.34M. RXRX’s [@Biotechnology] market capitalization is $2.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABSI and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 3 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • ABSI’s TA Score: 3 bullish, 5 bearish.
  • RXRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а +2.21% price change this week, while RXRX (@Biotechnology) price change was -2.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ABSI is expected to report earnings on Aug 19, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.14B) has a higher market cap than ABSI($353M). ABSI YTD gains are higher at: 5.725 vs. RXRX (-22.041). ABSI has higher annual earnings (EBITDA): -93.91M vs. RXRX (-524.77M). RXRX has more cash in the bank: 500M vs. ABSI (134M). ABSI has less debt than RXRX: ABSI (8.92M) vs RXRX (92.9M). RXRX has higher revenues than ABSI: RXRX (59.8M) vs ABSI (4.82M).
ABSIRXRXABSI / RXRX
Capitalization353M2.14B16%
EBITDA-93.91M-524.77M18%
Gain YTD5.725-22.041-26%
P/E RatioN/AN/A-
Revenue4.82M59.8M8%
Total Cash134M500M27%
Total Debt8.92M92.9M10%
TECHNICAL ANALYSIS
Technical Analysis
ABSIRXRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 13 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LUSIX11.210.10
+0.90%
Lazard US Systematic Small Cap Eq Ins
MGTIX46.290.33
+0.72%
MFS Massachusetts Inv Gr Stk I
HWSAX74.270.44
+0.60%
Hotchkis & Wiley Small Cap Value A
IILGX29.830.16
+0.54%
Thrivent Global Stock S
BGCWX15.870.02
+0.14%
Baillie Gifford EAFE Plus All Cap 2

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
+2.97%
RXRX - ABSI
62%
Loosely correlated
+1.15%
CRSP - ABSI
60%
Loosely correlated
+0.97%
BEAM - ABSI
58%
Loosely correlated
+0.65%
ABCL - ABSI
57%
Loosely correlated
+1.33%
NTLA - ABSI
48%
Loosely correlated
+0.09%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+1.15%
CRSP - RXRX
72%
Closely correlated
+0.97%
BEAM - RXRX
64%
Loosely correlated
+0.65%
ABSI - RXRX
63%
Loosely correlated
+2.97%
ABCL - RXRX
61%
Loosely correlated
+1.33%
PRME - RXRX
58%
Loosely correlated
+1.30%
More